Haemophilus influenza type b conjugate vaccine (Wuhan Institute Of Biological Products)

b型流感嗜血杆菌结合疫苗(武汉生物制品研究所)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHaemophilus influenza type b conjugate vaccine (Wuhan Institute Of Biological Products)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPericarditisMeningitisArthritis +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPericarditisMeningitisArthritis +[8

Other Information

ATC CodeN/A
Related LinksN/A